Abele Stefan Andreas
Abele Stefan Andreas, CTOO, reported a transaction classified as exercise at Pharvaris N.V. involving 45000.000000 shares for an estimated $0.00. Reported holdings after the transaction were 44500.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Sep 15, 2026
- Filing date
- Sep 17, 2026
How reported position traded is calculated
Not calculated for derivative securities.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
PHVS price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0001193125-26-394103 Stock Option (Right to Buy)
- Transaction date
- Sep 15, 2026 Filed Sep 17, 2026, 05:22 PM · 2d delay
- Shares
- 45,000 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 44,500 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-6 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction. - derivative_transaction-16 points
is_derivative = true
Derivative exercise rows are less discretionary than open-market purchases.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Chief Technical Ops Officer
- F1
The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date. The shares were sold in connection with the exercise of stock options in a ca…
- F2
The reported price represents a weighted average sale price for shares sold in multiple transactions at prices ranging from $39.2150 to $39.27 per share. The shares sold were acquired upon vesting of…
- F3
25% of the option vested on November 15, 2024 with the remaining shares vesting in 1/48 monthly installments thereafter.
0 other transactions
0 recent txs